CAMP (Camp4 Therapeutics) Days Payable : 0.00 (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Days Payable?

Camp4 Therapeutics's average Accounts Payable for the three months ended in Dec. 2024 was $2.54 Mil. Camp4 Therapeutics's Cost of Goods Sold for the three months ended in Dec. 2024 was $0.00 Mil.

The historical rank and industry rank for Camp4 Therapeutics's Days Payable or its related term are showing as below:

CAMP's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 122.89
* Ranked among companies with meaningful Days Payable only.

Camp4 Therapeutics's Days Payable stayed the same from Sep. 2023 (0.00) to Dec. 2024 (0.00). stayed the same

Camp4 Therapeutics Days Payable Historical Data

The historical data trend for Camp4 Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Days Payable Chart

Camp4 Therapeutics Annual Data

Trend

Dec22

Dec23

Dec24

Days Payable

Camp4 Therapeutics Quarterly Data
	Dec22	Sep23	Dec23	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Camp4 Therapeutics's Days Payable

For the Biotechnology subindustry, Camp4 Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Camp4 Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Camp4 Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Camp4 Therapeutics's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (1.042	+	1.21)	/	2 )	/	0	*	365
=	1.126					/	0	*	365
=	N/A

Camp4 Therapeutics's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (3.873	+	1.21)	/	2 )	/	0	*	365 / 4
=	2.5415					/	0	*	365 / 4
=	N/A

Camp4 Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Camp4 Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA

Website

https://www.camp4tx.com

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.